학술논문
Hydrogen Sulfide Metabolizing Enzymes in the Intestinal Mucosa in Pediatric and Adult Inflammatory Bowel Disease
Document Type
Report
Author
Source
Antioxidants. November 2022, Vol. 11 Issue 11
Subject
Language
English
ISSN
2076-3921
Abstract
Author(s): Nathalie Stummer [1]; Daniel Weghuber [1]; René G. Feichtinger [1]; Sara Huber [2]; Johannes A. Mayr [1]; Barbara Kofler [1,2]; Daniel Neureiter [3]; Eckhard Klieser [3]; Sarah Hochmann [4]; [...]
Hydrogen sulfide (H[sub.2] S) is a toxic gas that has important regulatory functions. In the colon, H[sub.2] S can be produced and detoxified endogenously. Both too little and too much H[sub.2] S exposure are associated with inflammatory bowel disease (IBD), a chronic intestinal disease mainly classified as Crohn’s disease (CD) and ulcerative colitis (UC). As the pathogenesis of IBD remains elusive, this study’s aim was to investigate potential differences in the expression of H[sub.2] S-metabolizing enzymes in normal aging and IBD. Intestinal mucosal biopsies of 25 adults and 22 children with IBD along with those of 26 healthy controls were stained immunohistochemically for cystathionine-γ-lyase (CSE), 3-mercapto-sulfurtransferase (3-MST), ethylmalonic encephalopathy 1 protein (ETHE1), sulfide:quinone oxidoreductase (SQOR) and thiosulfate sulfurtransferase (TST). Expression levels were calculated by multiplication of the staining intensity and percentage of positively stained cells. Healthy adults showed an overall trend towards lower expression of H[sub.2] S-metabolizing enzymes than healthy children. Adults with IBD also tended to have lower expression compared to controls. A similar trend was seen in the enzyme expression of children with IBD compared to controls. These results indicate an age-related decrease in the expression of H[sub.2] S-metabolizing enzymes and a dysfunctional H[sub.2] S metabolism in IBD, which was less pronounced in children.
Hydrogen sulfide (H[sub.2] S) is a toxic gas that has important regulatory functions. In the colon, H[sub.2] S can be produced and detoxified endogenously. Both too little and too much H[sub.2] S exposure are associated with inflammatory bowel disease (IBD), a chronic intestinal disease mainly classified as Crohn’s disease (CD) and ulcerative colitis (UC). As the pathogenesis of IBD remains elusive, this study’s aim was to investigate potential differences in the expression of H[sub.2] S-metabolizing enzymes in normal aging and IBD. Intestinal mucosal biopsies of 25 adults and 22 children with IBD along with those of 26 healthy controls were stained immunohistochemically for cystathionine-γ-lyase (CSE), 3-mercapto-sulfurtransferase (3-MST), ethylmalonic encephalopathy 1 protein (ETHE1), sulfide:quinone oxidoreductase (SQOR) and thiosulfate sulfurtransferase (TST). Expression levels were calculated by multiplication of the staining intensity and percentage of positively stained cells. Healthy adults showed an overall trend towards lower expression of H[sub.2] S-metabolizing enzymes than healthy children. Adults with IBD also tended to have lower expression compared to controls. A similar trend was seen in the enzyme expression of children with IBD compared to controls. These results indicate an age-related decrease in the expression of H[sub.2] S-metabolizing enzymes and a dysfunctional H[sub.2] S metabolism in IBD, which was less pronounced in children.